Black Cohosh as Alternative Therapy for Treating Menopause-Related Anxiety
Generalized Anxiety Disorder, Menopause
About this trial
This is an interventional treatment trial for Generalized Anxiety Disorder focused on measuring Black Cohosh, Cimicifuga, Anxiety, Women, Complementary and Alternative Medicine
Eligibility Criteria
Inclusion Criteria: Currently experiencing menopause or postmenopausal Have symptoms of menopause-related anxiety Exclusion Criteria: Any form of generalized anxiety disorder (GAD) unrelated to menopause Onset of GAD at least 3 years prior to menopause or at least 5 years after menstruation has stopped Alcohol or drug dependence within 3 months prior to study entry Allergy to black cohosh History of hormone replacement therapy Current use of vaginal estrogen cream or phytoestrogens Current use of tranquilizers, antidepressants, or antianxiety therapies Abnormal uterine bleeding History of estrogen-dependent cancer History of endometrial hyperplasia (abnormal increase in cells) or endometrial cancer Rapidly growing uterine fibroids Abnormal finding upon gynecological examination that would interfere with the study Abnormal breast examination or mammogram Any unstable medical condition
Sites / Locations
- Depression Research Unit, University of Pennsylvania School of Medicine
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
1
2
Anxiolytic Therapy
Anxiolytic Therapy